Centene CorporationCNCEarnings & Financial Report
Centene Corporation is an American for-profit healthcare company based in the Greater St. Louis area, which is an intermediary for government-sponsored and privately insured healthcare programs. Centene ranked No. 23 on the 2025 Fortune 500.
CNC Q4 2025 Key Financial Metrics
売上高
$44.7B
粗利益
$2.6B
営業利益
$-1.7B
純利益
$-1.1B
粗利益率
5.7%
営業利益率
-3.9%
純利益率
-2.5%
前年比成長
23.2%
EPS
$-2.15
資金フロー
Centene Corporation Q4 2025 Financial Summary
Centene Corporation reported revenue of $44.7B for Q4 2025, with a net profit of $-1.1B (-2.5% margin). Cost of goods sold was $42.2B, operating expenses totaled $4.3B.
Key Financial Metrics
| Total Revenue | $44.7B |
|---|---|
| Net Profit | $-1.1B |
| Gross Margin | 5.7% |
| Operating Margin | -3.9% |
| Report Period | Q4 2025 |
Centene Corporation Annual Revenue by Year
Centene Corporation annual revenue history includes year-by-year totals (for example, 2025 revenue was $174.6B).
| Year | Annual Revenue |
|---|---|
| 2025 | $174.6B |
| 2024 | $145.5B |
| 2023 | $140.1B |
| 2022 | $135.5B |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $36.34B | $35.97B | $36.90B | $36.30B | $42.49B | $42.47B | $44.90B | $44.73B |
| 前年比成長 | 4.0% | 3.3% | 5.5% | 2.7% | 16.9% | 18.1% | 21.7% | 23.2% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $82.62B | $83.14B | $82.35B | $82.44B | $87.04B | $86.39B | $82.09B | $76.75B |
| 総負債 | $55.56B | $55.68B | $54.94B | $55.94B | $59.02B | $58.89B | $61.03B | $56.69B |
| 株主資本 | $26.96B | $27.35B | $27.31B | $26.41B | $27.92B | $27.41B | $20.95B | $19.95B |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $-456.0M | $2.17B | $-978.0M | $-587.0M | $1.51B | $1.78B | $1.36B | $437.0M |
Other Health Care Companies
ELV
Elevance Health
売上高
$49.7B
純利益
$547.0M
HUM
Humana
売上高
$32.5B
純利益
$-796.0M
MOH
Molina Healthcare
売上高
$11.4B
純利益
$-160.0M
UNH
UnitedHealth Group
売上高
$113.2B
純利益
$2.3B
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B
BAX
Baxter International
売上高
$3.0B
純利益
$-1.1B